108 related articles for article (PubMed ID: 31713877)
1. Comparative effectiveness of different antiplatelet agents at reducing TNF-driven inflammatory responses in a mouse model.
Lee HR; Park KY; Jeong YJ; Heo TH
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):432-438. PubMed ID: 31713877
[TBL] [Abstract][Full Text] [Related]
2. The anti-platelet drug cilostazol enhances heart rate and interrenal steroidogenesis and exerts a scant effect on innate immune responses in zebrafish.
Chang WC; Chen MJ; Hsiao CD; Hu RZ; Huang YS; Chen YF; Yang TH; Tsai GY; Chou CW; Chen RS; Chuang YJ; Liu YW
PLoS One; 2023; 18(10):e0292858. PubMed ID: 37903128
[TBL] [Abstract][Full Text] [Related]
3. Subacute administration of cilostazol modulates PLC-γ/PKC-α/p38/NF-kB pathway and plays vascular protective effects through eNOS activation in early stages of atherosclerosis development.
Brazão SC; Lima GF; Autran LJ; Mendes ABA; Dos Santos BA; Magliano DC; de Brito FCF; Motta NAV
Life Sci; 2023 Nov; 332():122082. PubMed ID: 37722587
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA
Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33287341
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the interventions in antineoplastic therapy by a clinical pharmacy service at a tertiary hospital in Brazil.
da Rocha C; Carlotto J; Zanis Neto J
J Oncol Pharm Pract; 2022 Jul; 28(5):1049-1055. PubMed ID: 34000918
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of six cycles of lenalidomide-based triplet induction before stem cell collection for newly diagnosed transplant-eligible multiple myeloma.
Yoshihara S; Yoshihara K; Shimizu Y; Imado T; Takatsuka H; Kawamoto H; Misawa M; Ifuku H; Ohe Y; Okada M; Fujimori Y
Hematology; 2021 Dec; 26(1):388-392. PubMed ID: 34000225
[TBL] [Abstract][Full Text] [Related]
7. An antibody-based amperometric biosensor for 20S proteasome activity and inhibitor screening.
Barsan MM; Diculescu VC
Analyst; 2021 May; 146(10):3216-3224. PubMed ID: 33999049
[TBL] [Abstract][Full Text] [Related]
8. The use of eculizumab as a bridge to retransplantation for chronic antibody-mediated rejection in a heart transplant recipient: a case report.
Kearney K; Macdonald P; Hayward C; Muthiah K
Eur Heart J Case Rep; 2021 May; 5(5):ytab180. PubMed ID: 33997604
[TBL] [Abstract][Full Text] [Related]
9.
Wang X; Ye C; Xun T; Mo L; Tong Y; Ni W; Huang S; Liu B; Zhan X; Yang X
Front Pharmacol; 2021; 12():663325. PubMed ID: 33995087
[TBL] [Abstract][Full Text] [Related]
10. Pegfilgrastim for primary prophylaxis of febrile neutropenia in multiple myeloma.
Cerchione C; Nappi D; Martinelli G
Support Care Cancer; 2021 Nov; 29(11):6973-6980. PubMed ID: 33990881
[TBL] [Abstract][Full Text] [Related]
11. New approaches to targeting the androgen receptor pathway in prostate cancer.
Velho PI; Bastos DA; Antonarakis ES
Clin Adv Hematol Oncol; 2021 Apr; 19(4):228-240. PubMed ID: 33989272
[TBL] [Abstract][Full Text] [Related]
12. Low dose venetoclax in combination with bortezomib, daratumumab, and dexamethasone for the treatment of relapsed/refractory multiple myeloma patients-a single-center retrospective study.
Regidor B; Goldwater MS; Wang J; Bujarski S; Swift R; Eades B; Emamy-Sadr M; Eshagian S; Schwartz G; Spektor TM; Berenson JR
Ann Hematol; 2021 Aug; 100(8):2061-2070. PubMed ID: 33987683
[TBL] [Abstract][Full Text] [Related]
13. KD-PACE Salvage Therapy for Aggressive Relapsed Refractory Multiple Myeloma, Plasma Cell Leukemia and Extramedullary Myeloma.
Alsouqi A; Khan M; Dhakal B; Du L; Harrell S; Hari P; Cornell RF
Clin Lymphoma Myeloma Leuk; 2021 Aug; 21(8):526-535. PubMed ID: 33985931
[TBL] [Abstract][Full Text] [Related]
14. Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons.
Schinke C; Fernandez Vallone V; Ivanov A; Peng Y; Körtvelyessy P; Nolte L; Huehnchen P; Beule D; Stachelscheid H; Boehmerle W; Endres M
Neurobiol Dis; 2021 Jul; 155():105391. PubMed ID: 33984509
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.
Patel O; Muller CJF; Joubert E; Rosenkranz B; Louw J; Awortwe C
PLoS One; 2021; 16(5):e0251069. PubMed ID: 33983968
[TBL] [Abstract][Full Text] [Related]
16. Voriconazole in the successful management of a case of Acanthamoeba-Cladosporium keratitis.
Raghavan A; Nair AV; N K; Venkatapathy N; Rammohan R
Am J Ophthalmol Case Rep; 2021 Jun; 22():101107. PubMed ID: 33981917
[TBL] [Abstract][Full Text] [Related]
17. Which Way to Choose for the Treatment of Metastatic Prostate Cancer: A Case Report and Literature Review.
Yang X; Jiang D; Li Y; Zhang T; Xu D; Chen X; Pang J
Front Oncol; 2021; 11():659442. PubMed ID: 33981608
[TBL] [Abstract][Full Text] [Related]
18. Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model.
Thangaraj JL; Ahn SY; Jung SH; Vo MC; Chu TH; Thi Phan MT; Kwon M; Lee KH; Kim M; Song GY; Yang DH; Ahn JS; Kim HJ; Cho D; Lee JJ
Cell Mol Immunol; 2021 Jul; 18(7):1652-1661. PubMed ID: 33980993
[TBL] [Abstract][Full Text] [Related]
19. Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer.
Ueda T; Shiraishi T; Ito S; Ohashi M; Matsugasumi T; Yamada Y; Fujihara A; Hongo F; Okihara K; Ukimura O
Sci Rep; 2021 May; 11(1):10094. PubMed ID: 33980956
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib for treatment-refractory autoimmune haemolytic anaemia following multivisceral transplantation.
Wong D; Thomas W; Butler A; Sharkey L
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 33980556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
